RERE ATRenew Inc.

NYSE atrenew.com


$ 4.04 $ 0.05 (1.25 %)    

Wednesday, 19-Nov-2025 11:18:33 EST
QQQ $ 599.94 $ 2.93 (0.49 %)
DIA $ 460.47 $ -1.05 (-0.23 %)
SPY $ 662.54 $ 1.74 (0.26 %)
TLT $ 89.05 $ -0.17 (-0.19 %)
GLD $ 375.88 $ -1.90 (-0.5 %)
$ 4.02
$ 4.00
$ 4.03 x 4,130
$ 4.04 x 628
$ 3.99 - $ 4.10
$ 2.00 - $ 4.93
1,532,600
na
589.14M
$ 0.56
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 preview-atrenews-earnings
Preview: ATRenew's Earnings
11/19/2025 16:01:18

 atrenew-sees-q3-sales-704953m-718912m-vs-725000m-est

ATRenew (NYSE:RERE) sees Q3 sales of $704.953 million-$718.912 million vs $725.000 million analyst estimate.

 atrenew-q2-adj-eps-009-beats-004-estimate-sales-696800m-beat-665000m-estimate

ATRenew (NYSE:RERE) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.04 by 125 pe...

 atrenew-sees-q2-2025-revenues-between-rmb4710b-and-rmb4810b-a-247-to-274-increase-yoy

ATRenew (NYSE:RERE) sees Q2 sales of $649.055 million-$662.836 million vs $4.98 billion analyst estimate.

 atrenew-q1-adj-eps-007-beats-005-estimate-sales-64130m-beat-63600m-estimate

ATRenew (NYSE:RERE) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by 40 per...

 preview-atrenews-earnings
Preview: ATRenew's Earnings
05/19/2025 15:02:10

 atrenew-opens-flagship-store-in-chinas-top-electronics-hub-to-boost-used-tech-market

ATRenew Inc. ("ATRenew" or the "Company") (NYSE:RERE), a leading technology-driven platform for pre-owned consu...

 rise-of-chinas-secondary-consumption-key-stocks-to-watch

China's shift to household consumption-driven growth has resulted in a surge in preowned and refurbished goods. PDD Holding...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION